Treatment of Accelerated & Blastic Phase Chronic Myeloid Leukemia
Treatment of CML in Accelerated & Blastic Phases
Imbruvica® Effective in Newly Diagnosed & Recurrent Chronic Lymphocytic Leukemia
Imbruvica® Rituxan combination superior to FCR chemotherapy for treatment of newly diagnosed CLL
Treatment of Adult Acute Lymphoblastic Leukemia
Cancer Connect - Treatment of Adult Acute Lymphoblastic Leukemia
Leukemia
Leukemia Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Leukemia Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Leukemia Overviews
Treatment of Adult Acute Lymphoblastic Leukemia
Cancer Connect - Treatment of Adult Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia: Overview and Treatment
Management of Acute Myeloid Leukemia: Induction, Consolidation, Precision Medicines and Stem Cell Transplantation.
Acute Myeloid Leukemia Treatment Options Expand With Recent FDA Approvals
FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia
Chronic Myeloid Leukemia
Diagnosis, useful terms and treatment of chronic myeloid leukemia - chronic phase.
Acute Leukemia
Blincyto Prolongs Survival in Acute Lymphoblastic Leukemia (ALL)
Studies continue to demonstrate that incorporation of Blincyto into ALL treatment improves patient outcomes.
Vidaza® May Provide Alternative Treatment for Elderly Patients with AML
Vidaza® May Provide Alternative Treatment for Elderly Patients with AML.
Venclexta® for Acute Myeloid Leukemia
Venclexta® expands treatment options for AML - ASCO 2020 update in elderly AML patients confirms benefit.
FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia
FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia
Chronic Leukemia
Treatment of Accelerated & Blastic Phase Chronic Myeloid Leukemia
Treatment of CML in Accelerated & Blastic Phases
Imbruvica® Effective in Newly Diagnosed & Recurrent Chronic Lymphocytic Leukemia
Imbruvica® Rituxan combination superior to FCR chemotherapy for treatment of newly diagnosed CLL
Allogenic Stem Cell Transplant for Acute Myeloid Leukemia
Allogenic stem cell transplant is a curative treatment option for individuals with newly diagnosed and recurrent AML.
STAMP inhibitor Asciminib (ABL001) for CML
Asciminib superior responses compared to Bosulif for treatment of chronic myeloid leukemia - active in T315I mutations
Leukemia Survivorship
Do CLL Patients Have an Increased Risk of Developing a New Cancer?
CLL patients are at increased risk of developing a new cancer including those taking Ibrutinib & BTK Inhibitors
Chronic Leukemia Patients at Higher Risk of Developing Malignant Melanoma
Dr Zent M.D. and colleagues report on relationship between leukemia and risk of developing melanoma.
Hydrocortisone Improves Neuropsychological Issues in Children with Leukemia
Hydrocortisone Significantly Improves Neuropsychological Issues in Some Children with Leukemia.
Link Between Allergies and Blood Cancers in Women
Link Between Allergies and Blood Cancers in Women